Jazz Pharma EVP Global Head of R&D and CMO Robert Iannone disposes of shares worth $19.23 million - JAZZ News | RalliesJazz Pharma EVP Global Head of R&D and CMO Robert Iannone disposes of shares worth $19.23 million
J
JAZZ• Robert Iannone reports option exercises and share sales
- Robert Iannone, EVP, Global Head of R&D & CMO at Jazz Pharmaceuticals, reported stock option exercises and share sales on Aug. 27.
- Disposed of 76,921 ordinary shares at weighted average prices from USD 247.86 to USD 252.76.
- Exercised options for 57,500 ordinary shares at USD 113.1 and USD 137.12.
- Beneficial ownership stood at 65,686 ordinary shares following the transactions.
APCX
•
